EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Cerebral Venous Thrombosis following Sacituzumab Govitecan in Metastatic Breast Cancer: A Case Report

Ahmed M Abdalhadi, Fadel Alqatati, Asiya Thakur, Ali Ali Alsuyihili, Muhammed Hajmusa, Mohammad Elhissi, Nabil E Omar

Case Reports in Oncology · 25.08.2026 · 19 (1) · 1542-1550

DOI: 10.1159/cro/abzag033 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Oncology, online erschienen am 25.08.2026. Verfasst von Ahmed M Abdalhadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cerebral venous thrombosis (CVT) is an uncommon but potentially serious cerebrovascular disorder that may occur in the setting of malignancy and other prothrombotic states. Prompt diagnosis with venous neuroimaging and early anticoagulation are central to management. Case Presentation: We report the case of a 33-year-old woman with metastatic hormone receptor-positive/HER2-negative breast cancer who developed intermittent right-sided tremor-like episodes shortly after her third cycle of sacituzumab govitecan. Magnetic resonance imaging demonstrated thrombosis involving the superior sagittal, right transverse, and right sigmoid sinuses, with extension into the visualized right internal jugular vein, and showed no intracranial metastases. She was treated initially with therapeutic enoxaparin, followed by apixaban, with early radiologic recanalization on follow-up MRV. Sacituzumab govitecan was continued after multidisciplinary discussion because a partial response of metastatic disease had been observed.

Conclusion

This case highlights the need to consider CVT in patients with cancer who present with acute neurologic symptoms during systemic therapy and highlights diagnostic and therapeutic challenges in this context. We found no clearly indexed prior published case of CVT temporally associated with sacituzumab govitecan.

Schlagwörter

Stichwörter der Autor:innen

Antibody-drug conjugateCase reportCerebral venous thrombosisMetastatic breast cancerSacituzumab govitecan

Autor:innen und Institutionen

  • Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Department of Internal Medicine and Medical Education, Hamad Medical Corporation, Doha, Qatar.
  • Department of Radiology, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Department of Pharmacy, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
  • Health Sciences Program, Clinical and Population Health Research, College of Pharmacy, Qatar University, Doha, Qatar.

Zitieren

APA

Abdalhadi, A. M., Alqatati, F., Thakur, A., Alsuyihili, A. A., Hajmusa, M., Elhissi, M., & Omar, N. E. (2026). Cerebral Venous Thrombosis following Sacituzumab Govitecan in Metastatic Breast Cancer: A Case Report. Case Reports in Oncology, 19(1), 1542-1550. https://doi.org/10.1159/cro/abzag033

Vancouver

Abdalhadi AM, Alqatati F, Thakur A, Alsuyihili AA, Hajmusa M, Elhissi M, et al. Cerebral Venous Thrombosis following Sacituzumab Govitecan in Metastatic Breast Cancer: A Case Report. Case Reports in Oncology. 2026;19(1):1542-1550. doi:10.1159/cro/abzag033

BibTeX
@article{Abdalhadi2026,
  author = {Abdalhadi, Ahmed M and Alqatati, Fadel and Thakur, Asiya and Alsuyihili, Ali Ali and Hajmusa, Muhammed and Elhissi, Mohammad and Omar, Nabil E},
  title = {Cerebral Venous Thrombosis following Sacituzumab Govitecan in Metastatic Breast Cancer: A Case Report},
  journal = {Case Reports in Oncology},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {1542--1550},
  doi = {10.1159/cro/abzag033}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche